Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Washington Roundup, April 2012

Executive Summary

The latest medical device regulatory and reimbursement news from Elsevier Business Intelligence’s “The Gray Sheet.” This month we cover CDRH’s plans to expand its Medical Device Epidemiology Network and the potential impact of the JOBS Act on life sciences start-up companies.

You may also be interested in...



FDA Launches Effort To Integrate Ortho Device Registries

FDA has organized a small group of stakeholders to map out a plan for an international registry of orthopedic implants to better assess outcomes and safety of the devices. The agency hopes to release a report within the next two months detailing a framework for putting the initiative together, officials said at a May 9 public meeting.

The EU’s New Batteries Regulation: When And How Its Requirements Will Impact Medtech

The EU Batteries Regulation is yet another legal instrument medical device manufacturers must address over the coming years alongside the core Medical Device and IVD Regulations.

Mental Health Top Of Mind For Increasingly Health-Anxious Brits, Kaizo Survey Finds

Worryingly, however, British consumers are also increasingly turning to social media for health information, and rejecting it if it conflicts with what they believe, or if it is not based on personal experience. 

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT035521

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel